The Impact Of Physician Communication On Family Inpatient Experience

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Boston Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Boston Medical Center
ClinicalTrials.gov Identifier:
NCT01298791
First received: February 16, 2011
Last updated: February 17, 2011
Last verified: February 2011
  Purpose

Patient satisfaction is affected by physician communication styles and communication at the bedside. The investigators are conducting a randomized controlled trial involving both providers and families to determine if providers sitting down while talking with families, will improve one aspect of quality care delivered during an inpatient stay as measured by patient/family satisfaction. The investigators will additionally study the affects of the intervention on the following outcomes: family assessment of provider communication, readmission rates, and length of stay.


Condition Intervention
Parental/Patient Satisfaction
Behavioral: Sitting
Behavioral: Standing

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: The Impact Of Physician Communication On Family Inpatient Experience

Further study details as provided by Boston Medical Center:

Primary Outcome Measures:
  • Patient/family satisfaction [ Time Frame: 4mo ] [ Designated as safety issue: No ]
    Questionnaire obtains basic provider information

  • Patient/family Satisfaction [ Time Frame: 4 mo ] [ Designated as safety issue: No ]
    Caregiver questionnaire obtains baseline information on caregiver and patients

  • Patient/family satisfaction [ Time Frame: 4 months ] [ Designated as safety issue: No ]
    PSQ-18: Assesses parental satisfaction with medical care


Secondary Outcome Measures:
  • Length of stay [ Time Frame: 4 months ] [ Designated as safety issue: No ]
    Chart review of length of inpatient hospitalization during intervention

  • Readmission rate [ Time Frame: 5 mo ] [ Designated as safety issue: No ]
    Chart review and parental contact regarding readmission for same reason of initial hospitalization

  • Family discharge preparedness [ Time Frame: 4 mo ] [ Designated as safety issue: No ]
    Brief PREPARED instrument

  • Follow-up appointment attendance [ Time Frame: 5 mo ] [ Designated as safety issue: No ]
    Chart review and communication with caregivers regarding keeping follow-up appointment

  • Family assessment of doctor-patient communication skills [ Time Frame: 4 mo ] [ Designated as safety issue: No ]
    Crossley Communication Questionnaire


Estimated Enrollment: 120
Study Start Date: February 2011
Estimated Study Completion Date: August 2011
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Provider sitting
Providers seated during communication through hospitalization
Behavioral: Sitting
Providers will sit during inpatient family-centered walk rounds throughout the communication during rounds. The participating members of the care team (attending physician, resident and medical student) will remain seated while communicating with the patient and caregiver.
Experimental: Provider standing (control)
Providers standing during communication through hospitalization
Behavioral: Standing
Providers will stand during inpatient family-centered walk rounds throughout the communication during rounds. The participating members of the care team (attending physician, resident and medical student) will remain standing while communicating with the patient and caregiver.

  Eligibility

Ages Eligible for Study:   up to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Providers: all attendings, residents, and medical students involved in the care of patients on the pediatric inpatient wards during the study period.
  • Families (Parents or legal guardians and children):
  • (1) inpatient admissions to the pediatrics medical service at Boston Medical Center
  • (2) whose parents or guardian have agreed to participate in family centered walk rounds
  • (3) patients age 17 or younger who have family members present at the bedside each morning of hospitalization
  • (4) English speaking.

Exclusion Criteria:

  • (1) All patients/families that as part of admission justification involves social assessment and concern by the patient care team, including patients with neonatal abstinence syndrome, child maltreatment, and concern for neglect.
  • (2) All patients transferred to or from PICU as part of their inpatient care
  • (3) All patients transferred from an outside institution to the inpatient ward for further care secondary to progression of disease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01298791

Contacts
Contact: Michael Silverstein, MD, MPH 617-414-7903 michael.silverstein@bmc.org

Locations
United States, Massachusetts
Boston Medical Center Recruiting
Boston, Massachusetts, United States, 02118
Contact: Michael Silverstein, MD, MPH         
Principal Investigator: Michael Silverstein, MD, MPH         
Sub-Investigator: Duncan M Henry, MD         
Sub-Investigator: Israel Green-Hopkins, MD         
Sponsors and Collaborators
Boston Medical Center
Investigators
Principal Investigator: Michael Silverstein, MD, MPH Boston Medical Center
  More Information

No publications provided

Responsible Party: Michael Silverstein, MD, MPH, Boston Medical Center
ClinicalTrials.gov Identifier: NCT01298791     History of Changes
Other Study ID Numbers: 34423
Study First Received: February 16, 2011
Last Updated: February 17, 2011
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on October 29, 2014